A Computational Chemistry IPO From Schrodinger
Elon Musk once said that there’s a one in a billion chance we’re not living in a simulation. Sounds far-fetched until you start digging into simulation theory a bit. It’s backed by theories from leading academics, like Nick Bostrom’s “simulation argument,” which presents three likelihoods, each equally frightening to ponder. To paraphrase Arthur C. Clarke, it is as fascinating to think we’re alone in the universe as it is to think we’re not. What makes simulation theory even more credible are the recent advancements being made in modeling real-world biological entities. Companies like Turbine.ai are actually simulating cancer cells in virtual environments, then testing the accuracy of their efforts by mimicking wet lab tests. It’s similar to computational chemistry, a branch of chemistry that uses computer simulations to assist in solving chemical problems. Today, we’re going to look at a computational chemistry company that just filed for an IPO.
Schrödinger and Computational Chemistry
Firstly, let’s distinguish b
